Hc45

Hc45 is a topical product containing the corticosteroid active ingredient Hydrocortisone Acetate. The formulation is intended for skin application, though specific strength and dosage form are not disclosed. It is marketed in the European Union and belongs to the class of topical corticosteroids used to manage inflammatory skin conditions.

Hc45 is applied to the skin to alleviate symptoms of various inflammatory dermatologic disorders. It is commonly employed by healthcare professionals for short‑term management of conditions that respond to corticosteroid therapy.

- Treatment of mild to moderate dermatitis - Relief of eczema flare‑ups - Management of localized inflammatory skin lesions - Adjunct therapy for psoriasis plaques - Soothing of allergic skin reactions

Topical Hydrocortisone Acetate can cause a range of skin‑related reactions, most of which are mild and reversible. Serious adverse events are uncommon but may require medical attention.

Common: - Mild burning or stinging at the application site - Transient itching or redness - Slight skin thinning with prolonged use

Serious: - Development of secondary bacterial, fungal, or viral skin infections - Allergic contact dermatitis manifesting as rash or swelling - Systemic absorption leading to adrenal suppression (rare with extensive use)

Before using Hc45, consider the following safety measures to minimize risks and ensure appropriate use.

- Avoid application on broken, infected, or ulcerated skin unless directed by a clinician - Limit use to the prescribed area and duration to reduce skin atrophy - Do not cover treated skin with occlusive dressings unless advised - Consult a healthcare professional before use in children or the elderly - Discontinue and seek medical advice if signs of infection appear - Review pregnancy and lactation status with a provider, as safety data are limited

Hc45 may interact with other topical agents or systemic medications that affect corticosteroid activity. Consider these interactions when planning treatment.

Avoid: - Concurrent use of other potent topical steroids on the same area - Application of topical antibiotics or antifungals that may irritate the skin - Use with systemic immunosuppressants without monitoring

Use with caution: - Combining with non‑steroidal anti‑inflammatory creams - Applying over large body surface areas in patients with diabetes - Use in conjunction with photosensitizing agents - Concurrent use of oral corticosteroids, which may increase systemic effects